WHY BIG PHARMA IS DEAD IN THE WATER—GET READY TO STEP-UP TO THE PLATE

Unused/expired injections, and their components, are located all over the globe—who is going to sort it out?

THE WHY

• Between 1985 and 1995, Big Pharma sold off its facilities and skilled people that created its products.

• When less products came through, it engaged in horizontal M&A activity that cost $BNs but didn’t help—in fact, things got more complex, and failure became endemic.

• Then, Big Pharma focussed on rare disease, orphan indications and all things cancer—the volumes were so small, that to impress investors, it had to charge unaffordable, eye-watering prices.

• They tried $1M per treatment